Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 59

    1.

    Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection.

    Clifford GM, Lise M, Franceschi S, Egger M, Bouchardy C, Korol D, Levi F, Ess S, Jundt G, Wandeler G, Fehr J, Schmid P, Battegay M, Bernasconi E, Cavassini M, Calmy A, Keiser O, Schöni-Affolter F; Swiss HIV Cohort Study.

    Br J Cancer. 2012 Jan 31;106(3):447-52. doi: 10.1038/bjc.2011.558. Epub 2012 Jan 12.

    PMID:
    22240797
    [PubMed - indexed for MEDLINE]
    2.

    Combined effect of ALK and MEK inhibitors in EML4-ALK-positive non-small-cell lung cancer cells.

    Tanizaki J, Okamoto I, Takezawa K, Sakai K, Azuma K, Kuwata K, Yamaguchi H, Hatashita E, Nishio K, Janne PA, Nakagawa K.

    Br J Cancer. 2012 Feb 14;106(4):763-7. doi: 10.1038/bjc.2011.586. Epub 2012 Jan 12.

    PMID:
    22240786
    [PubMed - indexed for MEDLINE]
    3.

    Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB-IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial trial (FAST).

    Boni C, Tiseo M, Boni L, Baldini E, Recchia F, Barone C, Grossi F, Germano D, Matano E, Marini G, Labianca R, Di Costanzo F, Bagnulo A, Pennucci C, Caroti C, Mencoboni M, Zanelli F, Prochilo T, Cafferata MA, Ardizzoni A; Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC).

    Br J Cancer. 2012 Feb 14;106(4):658-65. doi: 10.1038/bjc.2011.606. Epub 2012 Jan 12.

    PMID:
    22240782
    [PubMed - indexed for MEDLINE]
    4.

    Estimating the asbestos-related lung cancer burden from mesothelioma mortality.

    McCormack V, Peto J, Byrnes G, Straif K, Boffetta P.

    Br J Cancer. 2012 Jan 31;106(3):575-84. doi: 10.1038/bjc.2011.563. Epub 2012 Jan 10.

    PMID:
    22233924
    [PubMed - indexed for MEDLINE]
    5.

    Inhibition of hyaluronan retention by 4-methylumbelliferone suppresses osteosarcoma cells in vitro and lung metastasis in vivo.

    Arai E, Nishida Y, Wasa J, Urakawa H, Zhuo L, Kimata K, Kozawa E, Futamura N, Ishiguro N.

    Br J Cancer. 2011 Dec 6;105(12):1839-49. doi: 10.1038/bjc.2011.459. Epub 2011 Nov 1.

    PMID:
    22045192
    [PubMed - indexed for MEDLINE]
    6.

    2. Tobacco-attributable cancer burden in the UK in 2010.

    Parkin DM.

    Br J Cancer. 2011 Dec 6;105 Suppl 2:S6-S13. doi: 10.1038/bjc.2011.475. No abstract available.

    PMID:
    22158323
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    7.

    PET imaging of patients with non-small cell lung cancer employing an EGF receptor targeting drug as tracer.

    Memon AA, Weber B, Winterdahl M, Jakobsen S, Meldgaard P, Madsen HH, Keiding S, Nexo E, Sorensen BS.

    Br J Cancer. 2011 Dec 6;105(12):1850-5. doi: 10.1038/bjc.2011.493. Epub 2011 Nov 17.

    PMID:
    22095231
    [PubMed - indexed for MEDLINE]
    8.

    PTEN and PIK3CA gene copy numbers and poor outcomes in non-small cell lung cancer patients with gefitinib therapy.

    Fidler MJ, Morrison LE, Basu S, Buckingham L, Walters K, Batus M, Jacobson KK, Jewell SS, Coon J 4th, Bonomi PD.

    Br J Cancer. 2011 Dec 6;105(12):1920-6. doi: 10.1038/bjc.2011.494. Epub 2011 Nov 17.

    PMID:
    22095222
    [PubMed - indexed for MEDLINE]
    9.

    Overexpression of TMPRSS4 in non-small cell lung cancer is associated with poor prognosis in patients with squamous histology.

    Larzabal L, Nguewa PA, Pio R, Blanco D, Sanchez B, Rodríguez MJ, Pajares MJ, Catena R, Montuenga LM, Calvo A.

    Br J Cancer. 2011 Nov 8;105(10):1608-14. doi: 10.1038/bjc.2011.432.

    PMID:
    22067904
    [PubMed - indexed for MEDLINE]
    10.

    Comment on 'Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab'.

    Shimokawa H, Uramoto H, Tanaka F.

    Br J Cancer. 2011 Oct 25;105(9):1465-6; author's reply 1467. doi: 10.1038/bjc.2011.412. Epub 2011 Oct 11. No abstract available.

    PMID:
    21989187
    [PubMed - indexed for MEDLINE]
    11.

    Randomised, phase III trial of epoetin-β to treat chemotherapy-induced anaemia according to the EU regulation.

    Fujisaka Y, Sugiyama T, Saito H, Nagase S, Kudoh S, Endo M, Sakai H, Ohashi Y, Saijo N.

    Br J Cancer. 2011 Oct 25;105(9):1267-72. doi: 10.1038/bjc.2011.395. Epub 2011 Sep 29.

    PMID:
    21959870
    [PubMed - indexed for MEDLINE]
    12.

    Host-derived MMP-13 exhibits a protective role in lung metastasis of melanoma cells by local endostatin production.

    Fukuda H, Mochizuki S, Abe H, Okano HJ, Hara-Miyauchi C, Okano H, Yamaguchi N, Nakayama M, D'Armiento J, Okada Y.

    Br J Cancer. 2011 Nov 8;105(10):1615-24. doi: 10.1038/bjc.2011.431. Epub 2011 Oct 20.

    PMID:
    22015555
    [PubMed - indexed for MEDLINE]
    13.

    Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer.

    Lecharpentier A, Vielh P, Perez-Moreno P, Planchard D, Soria JC, Farace F.

    Br J Cancer. 2011 Oct 25;105(9):1338-41. doi: 10.1038/bjc.2011.405. Epub 2011 Oct 4.

    PMID:
    21970878
    [PubMed - indexed for MEDLINE]
    14.

    HPV in exhaled breath condensate of lung cancer patients.

    Carpagnano GE, Koutelou A, Natalicchio MI, Martinelli D, Ruggieri C, Di Taranto A, Antonetti R, Carpagnano F, Foschino-Barbaro MP.

    Br J Cancer. 2011 Oct 11;105(8):1183-90. doi: 10.1038/bjc.2011.354. Epub 2011 Sep 27.

    PMID:
    21952627
    [PubMed - indexed for MEDLINE]
    15.

    A truncated form of CD9-partner 1 (CD9P-1), GS-168AT2, potently inhibits in vivo tumour-induced angiogenesis and tumour growth.

    Colin S, Guilmain W, Creoff E, Schneider C, Steverlynck C, Bongaerts M, Legrand E, Vannier JP, Muraine M, Vasse M, Al-Mahmood S.

    Br J Cancer. 2011 Sep 27;105(7):1002-11. doi: 10.1038/bjc.2011.303. Epub 2011 Aug 23.

    PMID:
    21863033
    [PubMed - indexed for MEDLINE]
    16.

    A multicentre phase II randomised trial of weekly docetaxel/gemcitabine followed by erlotinib on progression, vs the reverse sequence, in elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0504 study).

    LeCaer H, Barlesi F, Corre R, Jullian H, Bota S, Falchero L, Vergnenegre A, Dujon C, Delhoume JY, Chouaid C; GFPC 0504 Team.

    Br J Cancer. 2011 Oct 11;105(8):1123-30. doi: 10.1038/bjc.2011.331. Epub 2011 Sep 20.

    PMID:
    21934690
    [PubMed - indexed for MEDLINE]
    17.

    Phase I study of irinotecan and gefitinib in patients with gefitinib treatment failure for non-small cell lung cancer.

    Horiike A, Kudo K, Miyauchi E, Ohyanagi F, Kasahara K, Horai T, Nishio M.

    Br J Cancer. 2011 Oct 11;105(8):1131-6. doi: 10.1038/bjc.2011.375. Epub 2011 Sep 13.

    PMID:
    21915126
    [PubMed - indexed for MEDLINE]
    18.

    Socioeconomic position, stage of lung cancer and time between referral and diagnosis in Denmark, 2001-2008.

    Dalton SO, Frederiksen BL, Jacobsen E, Steding-Jessen M, Østerlind K, Schüz J, Osler M, Johansen C.

    Br J Cancer. 2011 Sep 27;105(7):1042-8. doi: 10.1038/bjc.2011.342. Epub 2011 Sep 6.

    PMID:
    21897390
    [PubMed - indexed for MEDLINE]
    19.

    Erlotinib 'dosing-to-rash': a phase II intrapatient dose escalation and pharmacologic study of erlotinib in previously treated advanced non-small cell lung cancer.

    Mita AC, Papadopoulos K, de Jonge MJ, Schwartz G, Verweij J, Mita MM, Ricart A, Chu QS, Tolcher AW, Wood L, McCarthy S, Hamilton M, Iwata K, Wacker B, Witt K, Rowinsky EK.

    Br J Cancer. 2011 Sep 27;105(7):938-44. doi: 10.1038/bjc.2011.332. Epub 2011 Aug 30.

    PMID:
    21878940
    [PubMed - indexed for MEDLINE]
    20.

    Lung cancer incidence and survival in different ethnic groups in South East England.

    Jack RH, Davies EA, Møller H.

    Br J Cancer. 2011 Sep 27;105(7):1049-53. doi: 10.1038/bjc.2011.282. Epub 2011 Aug 23.

    PMID:
    21863024
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk